![Peter Verwaijen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Verwaijen
Corporate Officer/Principal chez
EGETIS THERAPEUTICS AB
Profil
Peter Verwaijen is currently the Global Head-Brand Strategy & Commercial Business at Egetis Therapeutics AB since 2024.
Formerly, Mr. Verwaijen was Controller at Glaucus Proteomics BV and Vice President-Finance at AM-Pharma BV.
Postes actifs de Peter Verwaijen
| Sociétés | Poste | Début |
|---|---|---|
| EGETIS THERAPEUTICS AB | Corporate Officer/Principal | 01/10/2024 |
Anciens postes connus de Peter Verwaijen
| Sociétés | Poste | Fin |
|---|---|---|
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology Provides biopharmaceutical products | Directeur Financier/CFO | - |
Glaucus Proteomics BV
 Glaucus Proteomics BV Miscellaneous Commercial ServicesCommercial Services Develops antibody and protein array technologies to optimize drug development and disease management | Comptroller/Controller/Auditor | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Glaucus Proteomics BV
Glaucus Proteomics BV Miscellaneous Commercial ServicesCommercial Services Develops antibody and protein array technologies to optimize drug development and disease management | Commercial Services |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology Provides biopharmaceutical products | Health Technology |
Egetis Therapeutics AB
 Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
